Abdelilah Majdoubi

Abdelilah Majdoubi

Auto-generated profile, based on publicly available information

Abdelilah Majdoubi

British Columbia Children's Hospital Research Institute, Vancouver, British Columbia V5Z 4H4, Canada

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2018 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
JLJun Seong Lee
Jun Seong Lee
SJSe-Jin Jeong
Se-Jin Jeong
SKSinai Kim
Sinai Kim
LCLorraine Chalifour
Lorraine Chalifour
TYTae Jin Yun
Tae Jin Yun
CCCheolho Cheong
Cheolho Cheong
Ischemic myocardial injury results in sterile cardiac inflammation that leads to tissue repair, two processes controlled by mononuclear phagocytes. Despite global burden of cardiovascular diseases, we do not understand the functional contribution to pathogenesis of specific cardiac mononuclear phagocyte lineages, in particular dendritic cells. To address this limitation, we used detailed lineage tracing and genetic studies to identify bona fide murine and human CD103+ conventional dendritic cell (cDC)1s, CD11b+ cDC2s, and plasmacytoid DCs (pDCs) in the heart of normal mice and immunocompromised NSG mice reconstituted with human CD34+ cells, respectively. After myocardial infarction (MI), the specific depletion of cDCs, but not pDCs, improved cardiac function and prevented adverse cardiac remodeling. Our results showed that fractional shortening measured after MI was not influenced by the absence of pDCs. Interestingly, however, depletion of cDCs significantly improved reduction in fractional shortening. Moreover, fibrosis and cell areas were reduced in infarcted zones. This correlated with reduced numbers of cardiac macrophages, neutrophils, and T cells, indicating a blunted inflammatory response. Accordingly, mRNA levels of proinflammatory cytokines IL-1β and IFN-γ were reduced. Collectively, our results demonstrate the unequivocal pathological role of cDCs following MI.

22 April 2021 in JCI Insight
Verified
Journal Article
Open access
PDF file
AMAbdelilah Majdoubi
Abdelilah Majdoubi
CMChristina Michalski
Christina Michalski
SOSarah E. O’COnnell
Sarah E. O’COnnell
SDSarah Dada
Sarah Dada
SNSandeep Narpala
Sandeep Narpala
PLPascal Lavoie
Pascal Lavoie
Preexisting cross-reactivity to SARS-CoV-2 occurs in the absence of prior viral exposure. However, this has been difficult to quantify at the population level due to a lack of reliably defined seroreactivity thresholds. Using an orthogonal antibody testing approach, we estimated that about 0.6% of nontriaged adults from the greater Vancouver, Canada, area between May 17 and June 19, 2020, showed clear evidence of a prior SARS-CoV-2 infection, after adjusting for false-positive and false-negative test results. Using a highly sensitive multiplex assay and positive/negative thresholds established in infants in whom maternal antibodies have waned, we determined that more than 90% of uninfected adults showed antibody reactivity against the spike protein, receptor-binding domain (RBD), N-terminal domain (NTD), or the nucleocapsid (N) protein from SARS-CoV-2. This seroreactivity was evenly distributed across age and sex, correlated with circulating coronaviruses’ reactivity, and was partially outcompeted by soluble circulating coronaviruses’ spike. Using a custom SARS-CoV-2 peptide mapping array, we found that this antibody reactivity broadly mapped to spike and to conserved nonstructural viral proteins. We conclude that most adults display preexisting antibody cross-reactivity against SARS-CoV-2, which further supports investigation of how this may impact the clinical severity of COVID-19 or SARS-CoV-2 vaccine responses.

23 January 2024 in JCI Insight
Verified
Journal Article
Open access
PDF file
CMChristina Michalski
Christina Michalski
CCClaire Cheung
Claire Cheung
JOJu Hee Oh
Ju Hee Oh
EAEmma Ackermann
Emma Ackermann
CPConstantin R. Popescu
Constantin R. Popescu
PLPascal Lavoie
Pascal Lavoie
Pattern recognition receptor responses are profoundly attenuated before the third trimester of gestation in the relatively low-oxygen human fetal environment. However, the mechanisms regulating these responses are uncharacterized. Herein, genome-wide transcription and functional metabolic experiments in primary neonatal monocytes linked the negative mTOR regulator DDIT4L to metabolic stress, cellular bioenergetics, and innate immune activity. Using genetically engineered monocytic U937 cells, we confirmed that DDIT4L overexpression altered mitochondrial dynamics, suppressing their activity, and blunted LPS-induced cytokine responses. We also showed that monocyte mitochondrial function is more restrictive in earlier gestation, resembling the phenotype of DDIT4L-overexpressing U937 cells. Gene expression analyses in neonatal granulocytes and lung macrophages in preterm infants confirmed upregulation of the DDIT4L gene in the early postnatal period and also suggested a potential protective role against inflammation-associated chronic neonatal lung disease. Taken together, these data show that DDIT4L regulates mitochondrial activity and provide what we believe to be the first direct evidence for its potential role supressing innate immune activity in myeloid cells during development.

1 December 2019 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
AMAbdelilah Majdoubi
Abdelilah Majdoubi
JLJun Seong Lee
Jun Seong Lee
MBMohammad Balood
Mohammad Balood
ASAntoine Sabourin
Antoine Sabourin
ADAuriane DeMontigny
Auriane DeMontigny
JTJacques Thibodeau
Jacques Thibodeau
Dendritic cells (DCs) are critical players in skin homeostasis. A subset of mannose receptor (CD206)–expressing monocyte-derived DCs was found in skin, and their migratory counterpart is present in skin-draining lymph nodes (sdLNs). Skin CD206+ DCs were shown to upregulate MHC class II (MHCII) progressively, raising the question of whether this feature affects their biology. In this study, we assessed the role of MHCII regulation in the development and migration of these cells in mouse models expressing differential MHCII levels. Using CD206 as a surrogate marker, we found that skin CD206+ DCs develop in an MHCII-independent manner. However, their migration to sdLNs was affected by overexpression rather than absence or lower expression of MHCII. Accordingly, B16 tumor growth was exacerbated in mice overexpressing MHCII in the absence of ubiquitination. Mechanistically, CD206+ DCs from these mice showed decreased IRF4 and CCR7 expression. LPS, which is known to promote monocyte-derived DC recruitment to sdLNs, partially improved these defects. However, GM-CSF delivery restored CD206+ DC migration by promoting IRF4 expression. Collectively, these data show that MHCII downregulation is crucial for IRF4-dependent migration of CD206+ DCs to sdLNs in health and disease. Key Points MHCII molecule upregulation is not required for the development of skin moDCs. Skin CD206+ moDCs do not migrate to LNs in the absence of MHCII ubiquitination. GM-CSF restores the migration of skin moDCs by upregulating CCR7 and IRF4.

7 October 2020 in medRxiv
Verified
Preprint
Open access
PDF file
AMAbdelilah Majdoubi
Abdelilah Majdoubi
SOSarah E. O’connell
Sarah E. O’connell
CMChristina Michalski
Christina Michalski
SDSarah Dada
Sarah Dada
SNSandeep Narparla
Sandeep Narparla
PLPascal Lavoie
Pascal Lavoie
Background: Quantifying antibody reactivity against multiple SARS-CoV-2 antigens at the population level may help understand individual differences in COVID-19 severity. Pre-existing low antibody cross-reactivity may be particularly prevalent among childcare providers, including pediatric health care workers (HCW) who may be more exposed to circulating coronaviruses. Methods: Cross-sectional study that included adults in the Vancouver area in British Columbia (BC), Canada, between May 17 and June 19, 2020. SARS-CoV-2 seroprevalence was ascertained by measuring total SARS-CoV-2 IgG/M/A antibodies against a recombinant spike (S1) protein and adjusted for bias due to false-positive and false-negative test results. A novel, high sensitivity multiplex assay was also used to profile IgG against four SARS-CoV-2 antigens, SARS-CoV and four circulating coronaviruses. Findings: Among 276 participants (71% HCW), three showed evidence of direct viral exposure, yielding an adjusted seroprevalence of 0.60% [95%CI 0% – 2.71%], with no difference between HCW and non-HCW, or between paediatric and adult HCW. Among the 273 unexposed individuals, 7.3% [95%CI 4.5% – 11.1%], 48.7 [95%CI 42.7% – 54.8%] and 82.4% [95%CI 77.4% – 86.7%] showed antibody reactivity against SARS-CoV-2 RBD, N or Spike proteins, respectively. SARS-CoV-2 reactivity did not significantly correlate with age, sex, did not significantly differ between HCW and non-HCW (prevalence 1.0% vs 1.0%; P =1.00) and between pediatric and adult HCW (0.7% vs 1.6%; P =0.54), and modestly correlated with reactivity to circulating coronaviruses (Spearman rho range: 0.130 to 0.224 for 7 significant (FDR 5%), out of 16 correlations, from 36 correlations tested). Interpretation: A substantial proportion of individuals showed low, but detectable antibody reactivity against SARS-CoV-2 antigens in this population despite low evidence of direct SARS-CoV-2 exposure. Funding: NIAID/NIH

2 March 2026 in iScience
Verified
Journal Article
Open access
AMAbdelilah Majdoubi
Abdelilah Majdoubi
CMChristina Michalski
Christina Michalski
AWAllison W. Watts
Allison W. Watts
XDXiaoqing Dang
Xiaoqing Dang
SGS. Amirhossein Golzan
S. Amirhossein Golzan
PLPascal Lavoie
Pascal Lavoie
The long-term health burden of SARS-CoV-2 infections remains poorly understood. In a cohort from Vancouver, Canada, we identified immune imprinting to endemic β-human coronaviruses (HCoVs), reflected by affinity-matured IgG responses that cross-reacted with the SARS-CoV-2 spike with low affinity, along with an early expansion of memory B cells recognizing HKU1 and the conserved S2 domain following the first dose of ancestral-strain vaccination. Vaccination also enhanced antibody-dependent cellular phagocytosis (ADCP), primarily directed against the HKU1 spike and SARS-CoV-2 S2 domains. In another cohort from the same region, higher HKU1 spike IgG levels and increased antibody-dependent complement deposition (ADCD) were associated with a greater likelihood of post-COVID symptoms, even though these individuals had experienced fewer SARS-CoV-2 infections at the one-year follow-up. Together, these findings suggest that β-HCoV-associated immune imprinting may simultaneously reduce infection risk and promote pathological Fc-mediated inflammation, potentially contributing to post-COVID conditions following infection with contemporary SARS-CoV-2 variants in individuals vaccinated against earlier strains.